%0期刊文章%@ 1438- 8871% I Gunther Eysenbach %V 9% N 5% P e38% T移动网络监测和指导:慢性偏头痛的可行性%A Sorbi,Marjolijn J %A Mak,Sander B %A Houtveen,Jan H %A Kleiboer,Annet M %A van Doornen,Lorenz JP %+乌得勒支大学临床与健康心理学系，PO Box 80.140, 3508 TC乌得勒支，荷兰，+31 30 253 2384，m.j.sorbi@uu.nl %K个人数字助理%K生态监测%K电子产品%K偏头痛%K健康行为%K自我护理%K患者依从性%K患者满意度%D 2007 %7 31.12.2007 %9原始论文%J J医学互联网Res %G英语%X背景:互联网可以促进日记监测(经验采样，生态瞬间评估)和行为指导。在线数字辅助(ODA)是一种基于移动网络使用的通用工具，旨在作为面对面或基于互联网的认知行为治疗的辅助。目前的官方发展援助申请旨在支持以家庭为基础的慢性偏头痛行为发作预防培训，重点是识别发作前兆和支持预防性健康行为。目的:目的是在技术问题和参与者依从性方面建立ODA方法的可行性，以及基于用户友好性评分、潜在负担和对偏头痛行为发作预防培训的感知支持的ODA可接受性。方法:将移动电子日记监测与基于日记信息的直接人工在线健康行为指导相结合。日记包含以下三个部分:(1)偏头痛和药物使用，(2)发作前兆，(3)自我放松和其他预防行为;此外，监测月经(在晚上日记中评估)和睡眠紊乱(在早上日记中评估)。这项初步研究包括两组试验，共有5名女性患有无先兆的慢性偏头痛。 ODA was tested for 8.5 days (range 4-12 days) per participant. The first test run with three participants tested 4-5 diary prompts per day. The second run with another three participants (including one subject who participated in both runs) tested a reduced prompting scheme (2-3 prompts per day) and minor adaptations to the diary. Online coaching was executed twice daily on workdays. Results: ODA feasibility was established on the basis of acceptable data loss (1.2% due to the personal digital assistant; 5.6% due to failing Internet transmission) and good participant compliance (86.8% in the second run). Run 1 revealed some annoyance with the number of prompts per day. Overall ODA acceptability was evident by the positive participant responses concerning user-friendliness, absence of burden, and perceived support of migraine attack prevention. The software was adapted to further increase the flexibility of the application. Conclusions: ODA is feasible and well accepted. Tolerability is a sensitive issue, and the balance between benefit and burden must be considered with care. ODA offers a generic tool to combine mobile coaching with diary monitoring,independently of time and space. ODA effects on improvement of migraine remain to be established. %M 18166526 %R 10.2196/jmir.9.5.e38 %U //www.mybigtv.com/2007/5/e38/ %U https://doi.org/10.2196/jmir.9.5.e38 %U http://www.ncbi.nlm.nih.gov/pubmed/18166526